Government whistleblower lawsuit: PharMerica improperly dispensed, billed for narcotics

Share this article:
Former nursing home worker confesses to murdering resident in 2007
Former nursing home worker confesses to murdering resident in 2007

Long-term care pharmacy company PharMerica dispensed controlled narcotics without valid prescriptions and billed Medicare for the drugs, the federal government has charged in a False Claims Act lawsuit.

The government suit stems from a 2009 whistleblower complaint filed by Jennifer Denk, a former PharMerica employee. The company routinely filled nursing homes' orders for oxycodone and other Schedule II narcotics, even if there was not a proper prescription written by a doctor, Denk alleged. PharMerica also billed Medicare for these drugs, according to the suit.

“The complaint that we are filing today reflects the abiding commitment of the Justice Department to the qui tam process, encouraging people with information about alleged fraud and abuse to report it in a timely and effective manner,” James L. Santelle, U.S. Attorney for the Eastern District of Wisconsin, said Friday.

PharMerica “disputes the premises of the lawsuit” and will “vigorously defend itself,” the company stated yesterday.

Whistleblowers in these types of cases stand to receive a portion of monetary damages recovered by the government.

In June, PharMerica share prices slid on news that it had lost a major contract for skilled nursing pharmacy services with Kindred Healthcare. PharMerica retains its position as a major player in the sector, but has also faced increasing competition from relative newcomer AlixaRx.

Share this article:

More in News

Large hepatitis outbreak reaches 47 cases, podiatry company denies ManorCare's charges

The number of people infected in an infamous North Dakota Hepatitis C outbreak has risen, state health officials say.

National Quality Forum supports quality measures in bill to standardize post-acute assessments

National Quality Forum supports quality measures in bill ...

The National Quality Forum has come out in strong support of a proposed standardized quality measures, such as skin integrity, across different types of post-acute care settings. Uniform assessments are ...

CMS changes mind on hospice drugs

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.